Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Somani

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|July 1, 1981
Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disordersP Somani
Clinical Pharmacology and Therapeutics|April 1, 1980
Antiarrhythmic effects of flecainideP Somani
Journal of Clinical Pharmacology|May 1, 1989
Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodiesP Somani
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1975
Coronary vasodilator properties of ethyl adenosine 5-carboxylate hydrochloride (Abbott-40557)P Somani
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1973
Anti-arrhythmic action of beta-adrenergic receptor blocking agentsP Somani, S Kumakura
Canadian Journal of Physiology and Pharmacology|May 1, 1987
Pretreatment of human platelet membranes with trypsin abolishes GTP but not Na+ effects on alpha 2-adrenoreceptor-agonist interactionsS Periyasamy, P Somani
Hospital Topics|July 1, 1992
Hospital and public health agency relationshipsG Crum, P Somani
Journal of Chromatography|September 10, 1982
Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatographyV Simon, P Somani
Biochemical Pharmacology|September 15, 1986
Effect of proteases and phospholipases on [3H]yohimbine binding to human platelet membranesS Periyasamy, P Somani
European Journal of Pharmacology|March 1, 1974
The effect of LB-46, a beta-adrenoreceptor blocking drug, on isolated normal and ouabain-intoxicated Purkinje fibers of the dogS Kumakura, P Somani
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|July 1, 1981
Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disordersP Somani
Clinical Pharmacology and Therapeutics|April 1, 1980
Antiarrhythmic effects of flecainideP Somani
Journal of Clinical Pharmacology|May 1, 1989
Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodiesP Somani
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1975
Coronary vasodilator properties of ethyl adenosine 5-carboxylate hydrochloride (Abbott-40557)P Somani
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1973
Anti-arrhythmic action of beta-adrenergic receptor blocking agentsP Somani, S Kumakura
Canadian Journal of Physiology and Pharmacology|May 1, 1987
Pretreatment of human platelet membranes with trypsin abolishes GTP but not Na+ effects on alpha 2-adrenoreceptor-agonist interactionsS Periyasamy, P Somani
Hospital Topics|July 1, 1992
Hospital and public health agency relationshipsG Crum, P Somani
Journal of Chromatography|September 10, 1982
Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatographyV Simon, P Somani
Biochemical Pharmacology|September 15, 1986
Effect of proteases and phospholipases on [3H]yohimbine binding to human platelet membranesS Periyasamy, P Somani
European Journal of Pharmacology|March 1, 1974
The effect of LB-46, a beta-adrenoreceptor blocking drug, on isolated normal and ouabain-intoxicated Purkinje fibers of the dogS Kumakura, P Somani
Pageof 8